Streetbeat News

Regulatory

QQQ

SPY

The debt ceiling bill advanced to the House floor for debate and a final passage vote before going to the Senate. U.S. markets ended mixed on Tuesday, with options market outlooks for SPY and QQQ ETFs showing significant open interest accumulation at key trading levels.

Portfolio Pulse from Bhavik Nair

May 31, 2023 | 11:42 am

BIDU

Baidu has committed $140 million to finance Chinese startups exploring generative AI, tapping into the ChatGPT frenzy. The fund will be used to incubate projects built on Baidu's Ernie AI model. However, challenges include China's internet regulator requiring security reviews and the US semiconductor embargo affecting AI model training.

Portfolio Pulse from Anusuya Lahiri

May 31, 2023 | 11:15 am

RCKT

Rocket Pharmaceuticals has been granted PRIME designation by the European Medicines Agency (EMA) for its investigational gene therapy RP-A501 for the treatment of Danon Disease. The designation is based on positive safety and efficacy data from a Phase 1 clinical trial.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:11 am

BRTX

BioRestorative Therapies has received a license from the New York State Department of Health to act as a tissue bank for mesenchymal stem cell processing.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:07 am

BHVN

Biohaven Ltd. (NYSE:BHVN) will provide an overview of clinical progress, regulatory updates, and pipeline developments at an in-person R&D Day, concurrently with the Yale Ventures' Innovation Summit 2023.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:05 am

BCRX

BioCryst Pharmaceuticals will present two abstracts featuring data on ORLADEYO (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) at the 2023 European Academy of Allergy and Clinical Immunology (EAACI) congress in Hamburg, Germany.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:04 am

IGMS

IGM Biosciences has received FDA clearance to begin Phase 1b clinical studies of imvotamab, an IgM-based CD20 X CD3 bispecific antibody T cell engager, for severe systemic lupus erythematosus (SLE) and severe rheumatoid arthritis (RA). Patient enrollment is expected to start in Q3 2023.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:02 am

QQQ

SPY

US stock futures indicate a weaker open on Wednesday due to uncertainty over the budget bill and non-farm payroll data. Analyst Gina Bolvin sees potential for stock outperformance this year despite volatility. In premarket trading, SPY and QQQ ETFs fell 0.20% and 0.19% respectively.

Portfolio Pulse from Shanthi Rexaline

May 31, 2023 | 10:59 am

SPY

U.S. Republican Representative McHenry stated that the debt ceiling bill should pass on Wednesday, according to CNBC.

Portfolio Pulse from Charles Gross

May 31, 2023 | 10:39 am

BRTX

BioRestorative Therapies has announced that its license will enable expanded clinical operations for investigator-initiated trials and potential 'right to try' uses of BRTX-100.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 10:32 am